Brought to you by

Boehringer and MD Anderson collaborate in pancreatic cancer
03 Dec 2015
Executive Summary
Boehringer Ingelheim GMBH (BI) and MD Anderson Cancer Center entered into a collaboration for pancreatic ductal adenocarcinoma products.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com